These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9599798)
21. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus? Starkebaum G J Rheumatol; 2001 Dec; 28(12):2573-5. PubMed ID: 11764198 [No Abstract] [Full Text] [Related]
22. Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis. Soubrier M; Arrestier S; Bouloudian S; Dubost JJ; Ristori JM Joint Bone Spine; 2006 Mar; 73(2):218-9. PubMed ID: 16495108 [No Abstract] [Full Text] [Related]
23. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease. Perera SM; Thomas JA; Burke M; Crawford DH J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709 [TBL] [Abstract][Full Text] [Related]
24. Disseminated nasal T cell lymphoma with a partial deletion of the LMP1 oncogene in a patient with chronic active Epstein-Barr virus infection. Minegishi M; Ohashi Y; Tsuchiya S; Fujie H; Ichinohasama R; Nakagawa H; Konno T Leukemia; 1995 Sep; 9(9):1595-8. PubMed ID: 7658730 [No Abstract] [Full Text] [Related]
25. Primary cutaneous T-cell lymphoma with an angiocentric growth pattern: association with Epstein-Barr virus. Misago N; Ohshima K; Aiura S; Kikuchi M; Kohda H Br J Dermatol; 1996 Oct; 135(4):638-43. PubMed ID: 8915164 [TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Ferraccioli GF; Casatta L; Bartoli E; De Vita S; Dolcetti R; Boiocchi M; Carbone A Arthritis Rheum; 1995 Jun; 38(6):867-8. PubMed ID: 7779133 [No Abstract] [Full Text] [Related]
27. [Cutaneous pseudolymphoma during treatment of rheumatoid polyarthritis with low-dose methotrexate]. Delaporte E; Catteau B; Cardon T; Flipo RM; Lecomte-Houcke M; Piette F; Delcambre B; Bergoend H Ann Dermatol Venereol; 1995; 122(8):521-5. PubMed ID: 8572492 [TBL] [Abstract][Full Text] [Related]
28. [Aggressive non-Hodgkin lymphoma in 3 patients with rheumatoid arthritis: discontinue the use of methotrexate]. van Poppel PC; Fijnheer R; Haverman JF; Sinniqe HA Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2351-6. PubMed ID: 19024068 [TBL] [Abstract][Full Text] [Related]
30. Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study. Yao QY; Rickinson AB; Gaston JS; Epstein MA Clin Exp Immunol; 1986 May; 64(2):302-10. PubMed ID: 3017620 [TBL] [Abstract][Full Text] [Related]
31. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [TBL] [Abstract][Full Text] [Related]
32. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062 [TBL] [Abstract][Full Text] [Related]
33. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders. Yamada K; Oshiro Y; Okamura S; Fujisaki T; Kondo S; Nakayama Y; Suematsu E; Tamura K; Takeshita M Histopathology; 2015 Jul; 67(1):70-80. PubMed ID: 25429725 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature. Sekiguchi Y; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Ikeda K; Sekikawa I; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M Int J Clin Exp Pathol; 2015; 8(2):2090-102. PubMed ID: 25973110 [TBL] [Abstract][Full Text] [Related]
36. Diffuse large-cell lymphoma of B-cell origin and deficient T-cell function in a patient with rheumatoid arthritis. Weir AB; Herrod HG; Lester EP; Holbert J Arch Intern Med; 1989 Jul; 149(7):1688-90. PubMed ID: 2545174 [TBL] [Abstract][Full Text] [Related]
37. [Detection of Epstein-Barr virus in T cell lymphoma and clinicopathologic analysis]. He ZG; Huang YP; Guo XC; Lin DM; Zeng Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):229-33. PubMed ID: 15340564 [TBL] [Abstract][Full Text] [Related]
38. Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE. Kono H; Inokuma S; Matsuzaki Y; Nakayama H; Yamazaki J; Hishima T; Maeda Y J Rheumatol; 1999 Oct; 26(10):2249-53. PubMed ID: 10529149 [TBL] [Abstract][Full Text] [Related]